Cargando…

Prevalence of Mediterranean fever gene mutations in clinically suspected FMF patients in Algeria

Detalles Bibliográficos
Autores principales:	Ait-Idir, D, Bouldjennet, F, Taha, R, El-Shanti, H, Djerdjouri, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598879/ http://dx.doi.org/10.1186/1546-0096-13-S1-P94

Ejemplares similares

Familial Mediterranean Fever (FMF) before the age of one year
por: Delion, F, et al.
Publicado: (2008)

How long is the diagnosis of Familial Mediterranean Fever (FMF) delayed in a region where FMF is common in Turkey?
por: Karaaslan, Y, et al.
Publicado: (2015)

Attacks of severe dysmenorrhea as the sole manifestation of Familial Mediterranean Fever (FMF)
por: Vitale, A, et al.
Publicado: (2008)

The patient experience of Colchicine Resistant-Familial Mediterranean Fever (cr-FMF)
por: Dandekar, P, et al.
Publicado: (2015)

Behçet Disease (BD) in two siblings affected with Familial Mediterranean Fever (FMF)
por: Calcagno, G, et al.
Publicado: (2008)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

Familial Mediterranean Fever (FMF) and renal disease: first report on 29 Sicilian patients
por: Vitale, A, et al.
Publicado: (2008)

The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)
por: Wittkowski, H, et al.
Publicado: (2008)

The familial Mediterranean fever (FMF) 50 score: does it work in a controlled clinical trial? Re-analysis of the trial of rilonacept for patients with colchicine resistant or intolerant FMF
por: Hashkes, P, et al.
Publicado: (2015)

Chronic recurrent multifocal osteomyelitis in a patient with Familial Mediterranean Fever
por: Daia, A, et al.
Publicado: (2015)

Chronic destructive arthritis as an isolated symptom of familial Mediterranean fever (FMF) in a 17 year old Turkish boy
por: Dueckers, G, et al.
Publicado: (2011)

Compliance to colchicine treatment and disease activity in Familial Mediterranean Fever (FMF) patients in Middle/Black Sea Region of Turkey (in Çorum region)
por: Karaaslan, Y, et al.
Publicado: (2015)

Differential expression of miR-4520a is associated with gain of function mutations in Familial Mediterranean Fever (FMF)
por: Latsoudis, H, et al.
Publicado: (2015)

Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)
por: El Hasbani, Georges, et al.
Publicado: (2019)

Featuring the phenotype of the FMF prototype
por: Ben-Zvi, I, et al.
Publicado: (2015)

Clinical and subclinical features and MEFV mutation distribution in of FMF patients’ siblings
por: Gunduz, Z, et al.
Publicado: (2015)

NOD2/CARD 15 gene mutations in patients with Familial Mediterranean Fever
por: Berkun, Y, et al.
Publicado: (2011)

The role of oxidative stress in determining prognosis in children with FMF and the relationship between markers of oxidative stress and gene mutation
por: Eryavuz, O, et al.
Publicado: (2015)

Rheumatoid Arthritis and Familial Mediterranean Fever or Sacroiliitis Accompanied by FMF
por: Şahin, Ali, et al.
Publicado: (2013)

PReS-FINAL-2220: Cochlear involvement in FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

PReS-FINAL-2221: An earliest diagnosis of FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

Validity and reliability of medication adherence scale in FMF
por: Fidanci, BE, et al.
Publicado: (2015)

Coexistence of PFAPA syndrome and FMF in Armenian children
por: Mkrtchyan, N, et al.
Publicado: (2015)

Sweet's syndrome in a patient with compound heterozygous mutations in the Mediterranean fever gene (MEFV)
por: Michelson, M, et al.
Publicado: (2015)

PReS-FINAL-2205: Vascular risk assesment and MMP-3 gene in FMF
por: Sozeri, B, et al.
Publicado: (2013)

Anakinra for secondary amyloidosis in an adolescent with FMF and Behcet Disease
por: Bilginer, Y, et al.
Publicado: (2008)

PReS-FINAL-2219: Evaluation of autonomic function in FMF
por: Aktay Ayaz, N, et al.
Publicado: (2013)

PReS-FINAL-2222: FMF presenting with the features of malignancy
por: Keskindemirci, G, et al.
Publicado: (2013)

A child with cPAN as only manifestation of FMF
por: Khloyan, Gayane, et al.
Publicado: (2014)

Acute phase reactants in the follow-up of patients with FMF
por: Arıcı, ZS, et al.
Publicado: (2015)

How safe it is to treat pregnant FMF patients with Anakinra?
por: Ozdogan, H, et al.
Publicado: (2015)

Dimethylaminoparthenolide (DMAPT) as an alternative approach for treatment of Familial Mediterranean Fever (FMF)
por: Mosayebian, Ali, et al.
Publicado: (2021)

Profile of cytokines, growth factors and chemokines during attacks of FMF
por: Bilginer, Y, et al.
Publicado: (2008)

PReS-FINAL-2227: QT and JT dispersion in children with FMF
por: Fidanci, K, et al.
Publicado: (2013)

PReS-FINAL-2223: The relationship between FMF, BD and epilepsy
por: Sargsyan, H
Publicado: (2013)

Validity and reliability of medication adherence scale in FMF (adult version)
por: Fidanci, Berna Eren, et al.
Publicado: (2014)

Arterial stiffness as a model to dissect chronic inflammation in FMF
por: Kukuy, O, et al.
Publicado: (2015)

Increased prevalence of attention deficit hyperactivity disorder in children with Familial Mediterranean Fever
por: Lavi, E, et al.
Publicado: (2015)

Genetic analysis of MEFV mutation negative familial Mediterranean fever for non-MEFV mutations is rarely effective
por: Ben-Zvi, I, et al.
Publicado: (2015)

Familial Mediterranean Fever in Iran: A Report from FMF Registration Center
por: Salehzadeh, Farhad
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lep8lkpbk6e2spgpuombfsq8l4